Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
PRA-052 by Merck for Ulcerative Colitis: Likelihood of Approval
PRA-052 is under clinical development by Merck and currently in Phase I for Ulcerative Colitis. According to GlobalData, Phase I...